Results 161 to 170 of about 92,603 (242)

Heteroresistance to carbapenems in Acinetobacter baumannii [PDF]

Journal of Antimicrobial Chemotherapy, 2005
S, Pournaras, A, Ikonomidis, A, Markogiannakis, A N, Maniatis, A, Tsakris   +4 more
openaire   +2 more sources

Prevalence and antimicrobial-resistance characterization of vancomycin resistant enterococci (VRE) strains in healthy household dogs in Italy [PDF]

, 2016
DOTTO, GIORGIA, MARTINI, MARCO, MENANDRO, MARIA LUISA, MONDIN, ALESSANDRA, PASOTTO, DANIELA   +4 more
core   +1 more source

The glutathione pathway is required for biofilm formation in <i>Acinetobacter baumannii</i>. [PDF]

Curr Res Microb Sci
Thomas JM, Mosharaf Ghahfarokhy P, Rivera SGP, Nobile CJ, Rawat M.   +4 more
europepmc   +1 more source

Residual confounding and outcome definition in observational comparisons of PDR-<i>Acinetobacter baumannii</i> therapies. [PDF]

Antimicrob Agents Chemother
Külls C, Dadashpour N, Golestanieraghi M.   +2 more
europepmc   +1 more source

The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection models. [PDF]

J Antimicrob Chemother
van den Berg S, Pieren M, Sassen SDT, de Jong WAM, Boonman CSC, Dale GE, Muller AE.   +6 more
europepmc   +1 more source

Revisiting the Fight Against <i>Acinetobacter baumannii</i>: Emerging Non-Antibiotic Strategies. [PDF]

Antibiotics (Basel)
Montini VH, Buso LS, Takata PH, Santos GHM, Gonçalves BC, Endo TH, Santos MHM, Vespero EC, Kobayashi RKT, Nakazato G.   +9 more
europepmc   +1 more source

Peptidoglycan DD-peptidases have distinct activities that impact fitness of <i>Acinetobacter baumannii</i>. [PDF]

mBio
Tehrani AF, Khadka A, Furlan B, Whalen M, Biboy J, Massidda O, Vollmer W, Boll JM.   +7 more
europepmc   +1 more source

Cerebrospinal Pharmacokinetic and Pharmacodynamic Evaluation of Sulbactam: Dosing Considerations for Acinetobacter baumannii Meningitis in Pediatric Patients. [PDF]

J Pediatric Infect Dis Soc
Onita T, Ikawa K.
europepmc   +1 more source

Genomic characterisation of extensively drug-resistant Acinetobacter baumannii isolates from a tertiary hospital in Ghana. [PDF]

PLoS One
Ashley-Agbedor IE, Mahazu S, Kotey FCN, Amedior J, Adu B, Darko E, Kwao P, Dayie NTKD, Ablordey AS, Opintan JA.   +9 more
europepmc   +1 more source

Antivirulence drugs against Acinetobacter baumannii: where do they stand? [PDF]

World J Microbiol Biotechnol
Elanany AA, Khalifa AG, Attia AS.
europepmc   +1 more source